Structure (Aripiprazole Oral Solution 1)
Aripiprazole Solution
Product Images NDC 54838-570
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Aripiprazole (NDC 54838-570). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Lannett Company, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Carton (Aripiprazole Oral Solution 10)
This is a description of Aripiprazole Oral Solution, distributed by Lannatt Company, Inc. It is a medication used for various indications and is available in a 150mL package. Each mL contains 1 mg of aripiprazole in an aqueous solution. The medication guide must be dispensed by pharmacists to each patient. The solution should be stored at a controlled room temperature and not beyond the expiration date on the bottle. The enclosed dosing cup must be used to measure the correct amount.*
Bottle Label (Aripiprazole Oral Solution 11)
Figure 1 (Aripiprazole Oral Solution 2)
This appears to be a figure in a pharmacology study, showing the effects of other drugs on the pharmacokinetics of aripiprazole. The figure includes a chart with data on Cmax and Aue, as well as a graph showing the change in relative oral bioavailability of aripiprazole in the presence of different interacting drugs.*
Figure 2 (Aripiprazole Oral Solution 3)
The text contains a table titled Figure 2 evaluating the effects of other drugs on dehydro-aripiprazole pharmacokinetics. Therefore, the text appears to be useful for those interested in pharmacology or drug interactions.*
Figure 3 (Aripiprazole Oral Solution 4)
This is a description of Figure 3, which illustrates the effects of Aripiprazole on the pharmacokinetics of other drugs. The table shows changes relative to a reference (without interacting drug) for various medications, including Lopinavir, Midazolam, Propranolol, and Quetiapine. The changes are reported for parameters like AUC and Cmax.*
Figure 4 (Aripiprazole Oral Solution 5)
Figure 5 (Aripiprazole Oral Solution 6)
Figure 6 (Aripiprazole Oral Solution 7)
Figure 7 (Aripiprazole Oral Solution 8)
Figure 8 (Aripiprazole Oral Solution 9)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
